Next Article in Journal
Evaluation of the Mucoadhesive Properties of Chitosan-Based Microstructured Lipid Carrier (CH-MLC)
Next Article in Special Issue
Toxicokinetics of β-Amanitin in Mice and In Vitro Drug–Drug Interaction Potential
Previous Article in Journal
Report on Webinar Series Cell and Gene Therapy: From Concept to Clinical Use
Previous Article in Special Issue
Population Pharmacokinetics and Pharmacodynamic Target Attainment of Isavuconazole against Aspergillus fumigatus and Aspergillus flavus in Adult Patients with Invasive Fungal Diseases: Should Therapeutic Drug Monitoring for Isavuconazole Be Considered as Mandatory as for the Other Mold-Active Azoles?
 
 
Article

Article Versions Notes

Pharmaceutics 2022, 14(1), 167; https://doi.org/10.3390/pharmaceutics14010167
Action Date Notes Link
article pdf uploaded. 11 January 2022 15:55 CET Version of Record https://www.mdpi.com/1999-4923/14/1/167/pdf-vor
article xml file uploaded 12 January 2022 09:35 CET Original file -
article xml uploaded. 12 January 2022 09:35 CET Update -
article pdf uploaded. 12 January 2022 09:35 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/167/pdf-vor
article supplementary file uploaded. 12 January 2022 09:35 CET - https://www.mdpi.com/1999-4923/14/1/167#supplementary
article html file updated 12 January 2022 09:37 CET Original file -
article xml file uploaded 20 January 2022 11:35 CET Update -
article xml uploaded. 20 January 2022 11:35 CET Update https://www.mdpi.com/1999-4923/14/1/167/xml
article pdf uploaded. 20 January 2022 11:35 CET Updated version of record https://www.mdpi.com/1999-4923/14/1/167/pdf
article html file updated 20 January 2022 11:38 CET Update -
article html file updated 31 July 2022 03:16 CEST Update https://www.mdpi.com/1999-4923/14/1/167/html
Back to TopTop